News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
MiNK Therapeutics announced results for the fourth quarter and year-end of 2023
Photo: minkherapeutics.com
Mar 24, 2024, 13:10

MiNK Therapeutics announced results for the fourth quarter and year-end of 2023

MiNK Therapeutics shared on their LinkedIn page:

“Today MiNK announced results for the fourth quarter and year-end of 2023. Our year was marked by progress across our clinical programs, manufacturing capabilities, and research team, which continue to solidify MiNK’s leadership in the field of iNKT cell therapy.

Read more about the results and our plans for 2024 here.”

Image preview

Source: MiNK Therapeutics/LinkedIn

cancer Cell Therapy clinical progress iNKT cell therapy leadership team Medical Advancements MiNK Therapeutics OncoDaily Oncology research excellence
Special Coverage
Blog
Mar 29, 2025, 15:50
Mariana Fernandez: Thrilled to Have Participated in the 1st International Workshop on GPRC5D-Targeted Myeloma Therapies
Blog
Mar 29, 2025, 15:33
Dégi László Csaba: Owning our successes is how we secure the future of europe’s beating cancer plan by Anna Wagstaff
Science
Mar 29, 2025, 15:31
Sandra Cascio on the role of EGFL6 in modulating myeloid cells in the tumor microenvironment - OORC
Blog
Mar 29, 2025, 15:14
Invest in Staff for Better Productivity, Service, and Care: Women in Oncology
Blog
Mar 29, 2025, 15:03
Antonio Passaro: MARIPOSA Study Shows Amivantamab-Lazertinib Survival Benefit in EGFR-Mutant Lung Cancer
Blog
Mar 29, 2025, 15:02
Investigating the experience of families of children with cancer with SACT and pharmacy support - Larsen's Pride
Blog
Mar 29, 2025, 15:01
Will you give up a single coffee run for a brighter future for myeloma? - International Myeloma Foundation
Blog
Mar 29, 2025, 15:00
Highlights from the recent Train-the-Trainer course held at Turku University of Applied Sciences - ESO
Career
Mar 29, 2025, 14:44
Jeff Lee has been appointed as MD Anderson Cancer Center's Chief Medical Executive
Science
Mar 29, 2025, 14:33
Therapeutic Potential of 68Ga/177Lu-DOTATATE in Metastatic Medullary Thyroid Carcinoma by Majid Assadi et al.
Blog
Mar 29, 2025, 13:57
Introducing The Lancet Obstetrics, Gynaecology, and Women’s Health Journal - The Lancet
Blog
Mar 29, 2025, 13:29
Bilal Awad: My Blog about Colorectal Cancer Awareness Month - A Call to Action